метафилактика

Hypercalciuria is the main lithogenic metabolic disorders in patients with calcium urolithiasis. This metabolic sign could be seen most often with other metabolic risk factors of urolithiasis (hyperuricosuria, hyperoxaluria, hypocitraturia and hypomagniuria). Pathogenetic mechanisms of hypercalciuria development are manifold, which provide basis for different forms of hypercalciuria. 

In scientific research institute of urology of Russian health care department unified recommendations schemes of urate, calcium-oxalate and calcium-phosphate calculi formation prophylaxis were developed and already used for many years. They reflect tactics of management of stated groups of patients, contain information of chemical structure of calculi removed or drawn off by itself, disorders of lithogenous compounds exchange, which were the basement of scheme development. To evaluate the efficacy of long-term outpatient treatment of patients due to these sch

Using of magnesium medications in anti-relapse treatment of calcium urolithiasis is still in the center of urologists’ debates.

Recurrent calcium urolithiasis is often characterised by hyper excretion of magnesium in urine, which however is not a protective feature referring to calculi relapse, as far as in these patients have more severe recurrence clinical manifestation.

Article is dedicated to outpatient management of adults and children with urolithiasis. We have developed standards of equipment and recomendations of outpatient clinics managing urolithiasis based on our own long-term clinical experience analysis and international publications. Suggested protocol corresponds to basic aspects of diagnostic and treatment of patients with utolithiasis in outpatient conditions. Diagnostic and therapy procedures are divided into obligate and additional, used in children, young patients and in complicated patients.